Tae Kon Kim, MD, PhD

Dr. Tae Kon Kim is an Assistant Professor of Medicine in the Division of Hematology and Oncology. HIs research interests focus on dissecting mechanisms of immune evasion and developing new therapeutic modalities for the treatment of leukemia. He has received research training under the mentorship of Dr. Lieping Chen, a pioneer in the field of immuno-oncology responsible for key discoveries involving PD-L1 and its interaction with PD-1 in cancer patients. Dr. Kim's translational investigations have focused on the role of novel co-inhibitory molecules during immune evasion in leukemia. He is also interested in selectively inhibiting graft-versus-host disease with sparing graft-versus-leukemia by manipulating co-stimulatory and co-inhibitory molecules.  His achievements include receiving the American Society of Hematology Scholar Award, American Society of Clinical Oncology Career Development Award, the Evans MDS Young Investigator Award, and the American Cancer Society Clinician Scientist Development Grant.